Improving healthcare was a central theme of the latest episode of the Debunked Podcast. The discussion offered perspectives from Louisiana Republican Senator Bill Cassidy, HHS Secretary Robert Kennedy Jr., Devoted Health CEO Ed Park, and Dr. Ezekiel Emmanuel, an oncologist and professor with University of Pennsylvania, and Debunked co-hosts Arundhati Parmar and Samir Batra. The…
Alejandro Santillan-Garcia is worried he’s going to lose the aid that helps him buy food. The 20-year-old Austin resident qualified for federal food benefits last year because he aged out of the Texas foster care system, which he entered as an infant. The Supplemental Nutrition Assistance Program — commonly referred to as food stamps, or…
During a panel discussion at MedCity News’ INVEST Digital Health conference, three healthcare leaders shared their expert insight on what needs to change in order to improve the industry’s cybersecurity strategy. The post What Will It Take to Improve Healthcare Cybersecurity? appeared first on MedCity News.
As lawmakers consider stricter PBM regulation, Cigna launched a “rebate-free” model to give patients upfront drug discounts, but experts question whether it will lead to meaningful change. The post Cigna’s Rebate-Free Model Sounds Nice, But Experts Are Still Skeptical appeared first on MedCity News.
LAME DEER, Mont. — Misty Pipe had about an hour before her shift began at the post office. She used that time to check in on a new mom who lives a few miles outside this town at the heart of the Northern Cheyenne Indian Reservation. A mom of seven, Pipe is a doula on…
Lawmakers are applying increased scrutiny to private equity’s involvement in healthcare, particularly when it comes to physician practice roll-ups. But investor Matthew Bennett argues the pressure is reshaping rather than shrinking the sector, pushing firms away from roll-ups and toward strategies focused on improving outcomes and using technology to boost efficiency. The post How PE…
Patty Hayward is GM of Healthcare and Life Sciences at TalkDesk. TalkDesk runs the technology for contact centers that helps companies across health care connect and manage their consumers. You’ve probably unknowingly used their technology when you call (or now text or email) your health plan, your provider system or call into one of those…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Trump Team’s Rhetoric Doesn’t Match Actions The recent KFF Health News article “Beyond Ivy League, RFK Jr.’s NIH Slashed Science Funding Across States That Backed Trump” (April 17) struck a nerve….
Arcellx’s cell therapy for multiple myeloma has shown no signs of the parkinsonism complication observed in clinical testing of Carvykti, a rival product from partners Johnson & Johnon and Legend Biotech. Arcellx is developing its CAR T-treatment under a partnership with Gilead Sciences. The post Safety Stands Out in Arcellx Cell Therapy’s ASH Data, But…
Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence. The post FDA Drug Approval Marks a First for a Disease — But It’s Not Autism appeared first on MedCity…